Youth Vaping Is "Predictable" by Design - Scorecard - MDSpire

Youth Vaping Is "Predictable" by Design

Product engineering, not individual choice, is driving adolescent nicotine dependence, researchers argue.

  • By

  • Kerri Miller

  • June 5, 2026

  • 3 min

Share

Clinical Scorecard: Youth Vaping Is 'Predictable' by Design

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAdolescents aged 13 to 15 years
Care Setting

Key Highlights

  • Vaping prevalence among adolescents is nine times that of adults.
  • E-cigarette products with at least 5% nicotine strength increased by 1,486% from 2017 to 2022.
  • Evidence of harms in youth includes addiction, toxicity, and increased smoking uptake.
  • Long-term effects of e-cigarettes on clinical outcomes remain uncertain.

Guideline-Based Recommendations

Diagnosis

  • Recognize nicotine dependence in adolescents as influenced by product design and marketing.

Management

  • Implement pre-market safety standards and retailer licensing reform.

Monitoring & Follow-up

  • Monitor youth exposure to e-cigarettes and related health outcomes.

Risks

  • Acknowledge risks of addiction, toxicity, and other health harms associated with vaping.

Patient & Prescribing Data

Adolescents at risk of nicotine dependence due to vaping.

Focus on addressing upstream factors such as product design and marketing.

Clinical Best Practices

  • Incorporate discussions of product design and commercial systems in counseling.
  • Advocate for flavor restrictions and comprehensive tobacco control measures.

Related Resources & Content

Original Source(s)

Youth Vaping Is "Predictable" by Design

  • by Kerri Miller

  • June 5, 2026

Related Content

RSV Prevention Tied to Lower Infant Acute Care Use

Data suggest fewer respiratory syncytial virus–associated hospitalizations and emergency department visits among the youngest infants during the second season of routine prevention product use.

Medical Oddities: From Romance to Recall Issues

Mental health check: what patients eat, watch, love, and dream may all be in play

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.